网站大量收购闲置独家精品文档,联系QQ:2885784924

黄芪甲苷葡萄糖注射液治疗冠心病稳定型劳累性心绞痛的Ⅲ期临床分析-中西医结合临床专业毕业论文.docx

黄芪甲苷葡萄糖注射液治疗冠心病稳定型劳累性心绞痛的Ⅲ期临床分析-中西医结合临床专业毕业论文.docx

  1. 1、本文档共60页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
成都中医药大学硕士学位论文 成都中医药大学硕士学位论文 PAGE PAGE 2 中文摘要 目的:观察黄芪甲苷葡萄糖注射液治疗冠心病稳定型心绞痛的有效 性和安全性。 方法:从成都中医药大学、天津中医学院、贵阳中医学院及新疆维吾 尔自治区中医医院心血管内科门诊及住院部收集 432 例符合稳定型 劳累性心绞痛诊断标准的患者,采取随机、仿盲、阳性药平行对照设 计,分为试验组与对照组两组。试验组静脉滴注黄芪甲苷葡萄糖注射 液治疗,对照组静脉滴注丹参注射液治疗,疗程 2 周,观察治疗前后 各症状计分及相关检查变化情况。 结果:本次临床试验结果表明黄芪甲苷葡萄糖注射液对冠心病稳定型 心绞痛有较好的疗效,能明显缓解心绞痛及改善心肌缺血,试验组与 对照组治疗效果无显著差异(P0. 05)。试验过程中,未发生严重不 良事件,以及发现试验药物各组安全性指标未出现与试验药物有关的 治疗前正常/ 治疗后异常或治疗前异常/ 治疗后异常加重的情况。 结论:黄芪甲苷葡萄糖注射液治疗冠心病稳定型心绞痛疗效肯定,安 全有效。 关键词:冠心病 稳定型劳累性心绞痛 黄芪甲苷葡萄糖注射液 Abstract Objection:To investigate the clinical efficacy and security of Astragaloside Ⅳ Glucose on stable angine of coronary artery disease. Methods:432 cases of stable angine of coronary artery disease were enrolled from the clinic and admission department of heart Medical Department of chengdu、tianjin and guiyang university of TCM and traditional chinese medicine hospital of xinjiang weiwuer autonomous regine. We adopted stochastic and parallel control and immitated blind with positive control medicine.Treament group were treated with Astragaloside Ⅳ Glucose,while control group were treated with Salvia miltiorrhize injection.The course of treatment was two weeks.The symptoms and signs were observed both before and after treatment.The correlative eximations were taken before and after treatment. Result:The clinical test showed Astragaloside Ⅳ Glucose has good effect on stable angina of coronary artery disease,which could relieve angina and improve myocardial ischemia obviously.The therapeatic efficacy between treament group and control group without significant deviation. No obvious side effect was afound during treating.That safety index of trial medicine groups conditions like pretherapy normality / post-treatment abnormality or pretherapy abnormality/ post-treatment abnormality worsen which has some relationship with trial medicine groups were not discovered. Conclusion: Astragaloside Ⅳ Glucose can improve clinical symptom of stable angine of coronary artery disease.And it

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档